Amy E Pomeroy

9PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNeural networksSignal transduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 15, 2026
Functional genomics and proteomics identify Folate Carrier SLC19A1 as a predictor of pralatrexate sensitivity in diverse T-cell lymphoma models.

|Nov 24, 2025
Integrating functional genomics and proteomics identifies Folate Carrier SLC19A1 as a predictor of pralatrexate sensitivity in T-cell lymphoma.

Jacob C Pantazis, Amy E Pomeroy, Adam C Palmer

|Oct 27, 2025
A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell Lymphoma.

Amy E Pomeroy, Brian J Sworder, Deborah Plana

|Feb 24, 2025
A Model of Intratumor and Interpatient Heterogeneity Explains Clinical Trials of Curative Combination Therapy for Lymphoma.

Amy E Pomeroy, Adam C Palmer

|Mar 26, 2024
Ultrasensitive Response Explains the Benefit of Combination Chemotherapy Despite Drug Antagonism.

Sarah C Patterson, Amy E Pomeroy, Adam C Palmer

|Jan 17, 2024
Synergistic Drug Combinations Promote the Development of Resistance in Acute Myeloid Leukemia.

Emily Mason-Osann, Amy E Pomeroy, Adam C Palmer

Pageof 2

Frequent Collaborators

7 joint publications

Adam C Palmer

2 joint publications

Sarah C Patterson

2 joint publications

Jacob C Pantazis

1 joint publications

Matthew I Peña